Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb and Syngene International Extend Research Collaboration

[Business Wire] – PRINCETON, N.J. & BANGALORE, India–(BUSINESSWIRE)– Bristol-Myers Squibb (NYSE:BMY – News) and Syngene International, India’s largest contract research organization, today announced a five-year extension of their drug discovery and development collaboration . . . → Read More: Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb and Syngene International Extend Research Collaboration Similar Articles: Company Update (NYSE:BMY): Bristol-Myers Squibb Ranks First on 2014 Best Corporate Citizens List Company Update (NYSE:BMY): Bristol-Myers Squibb Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1 Market Update (NYSE:BMY): Bristol-Myers Squibb Submits NDAs for Daclatasvir and Asunaprevir to US FDA for the Treatment of Hepatitis C